United States

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934


        Date of Report (Date of earliest event reported): August 28, 2003

                                GPN Network, Inc.
                  ---------------------------------------------
                 (Exact name of registrant specified in charter)


     Delaware                     033-05384                     13-3301899
-------------------            ---------------              ------------------
     (State of                (Commission File                 (IRS Employer
   Incorporation)                  Number)                  Identification No.)


                      8655 East Via De Ventura, Suite E-155
                    Scottsdale, Arizona              85258
               --------------------------------------------------
               (Address of principal executive offices) (Zip Code)


                                 (480) 922-3926
               --------------------------------------------------
              (Registrant's telephone number, including area code)



                                       N/A
          -------------------------------------------------------------
          (Former name or former address, if changed since last report)







ITEM 5.   OTHER EVENTS.

          On August 28, 2003,  GPN Network,  Inc.  (the  "Registrant")  issued a
          press release  announcing its name change to IR Biosciences  Holdings,
          Inc. A copy of the press  release is attached as Exhibit  99.1 to this
          report.


ITEM 7.   FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.

          (c)    Exhibits:

          99.1   Press Release dated August 28, 2003 announcing the Registrant's
                 name change to IR Biosciences Holdings, Inc.





                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


                                            GPN Network, Inc.


                                            By: /s/ Michael Wilhelm
                                                --------------------------
                                                Michael Wilhelm, President

Dated:  August 29, 2003